Intal, a brand name for cromolyn sodium inhalation aerosol, is a medication used for the preventive management of bronchial asthma. Developed by Fisons
armaceutical/”>Ph
armaceuticals, now part of Aventis,
Intal has been a prominent treatment option for asthma since its introduction in the 1970s. This comprehensive guide aims to provide an in-depth understanding of
Intal, its ph
armacology, clinical use, and various aspects related to its administration and patient care.
armacology”>
The active ingredient in
Intal is cromolyn sodium, a chromone compound with anti-inflammatory properties. Its mechanism of action involves stabilizing mast cells and preventing the release of chemical mediators that trigger bronchospasms and airway inflammation. The chemical structure of cromolyn sodium is C
23H
16NaO
11 , and it is a synthetic derivative of the naturally occurring chromone complex. Source:
PubChem:
Cromolyn
Sodium
Intal is primarily indicated for the prophylactic management of bronchial asthma. It is used to prevent wheezing, shortness of breath, and other asthma symptoms triggered by various factors, including exercise,
allergens, and environmental irritants.
Intal is not a bronchodilator and should not be used to treat acute asthma attacks. Source:
FDA Label:
Intal
Inhalation Aerosol
Intal is available in various formulations for inhalation, including: The most common formulation is the metered-dose inhaler, which delivers a micronized cromolyn sodium aerosol directly to the lower airways. Proper administration technique is crucial for optimal drug delivery and efficacy. Source:
Drugs.com:
Intal
The recommended dosage of
Intal varies depending on the formulation, age, and severity of the condition. For the metered-dose inhaler, the typical adult dosage is 2 inhalations (20 mg) three or four times daily. Dosage adjustments may be necessary for children, elderly patients, or those with impaired renal or hepatic function. Detailed dosage guidelines and administration instructions are provided in the package insert and should be followed closely. Source:
FDA Label:
Intal
Inhalation Aerosol
Intal is generally well-tolerated, but some patients may experience side effects. Common side effects include cough, nasal congestion, nausea, and throat irritation. Severe adverse reactions, such as bronchospasm or anaphylaxis, are rare but can occur. Patients should be advised to report any persistent or worsening symptoms to their healthcare provider. Source:
Drugs.com:
Intal Side Effects
Intal is a non-steroidal anti-inflammatory drug (NSAID) and differs from other asthma medications, such as bronchodilators and corticosteroids. While it is not as potent as inhaled corticosteroids,
Intal may be a suitable alternative for patients who cannot tolerate or prefer to avoid steroids. Generic cromolyn sodium inhalation products are also available as cost-effective alternatives to the brand-name
Intal. Source:
NCBI BookShelf: Bronchial
Asthma Drugs
Numerous clinical trials have been conducted to evaluate the efficacy of
Intal in various populations and asthma subtypes. Overall,
Intal has been shown to be effective in preventing asthma symptoms and improving lung function when used as a prophylactic treatment. However, its efficacy may be lower compared to inhaled corticosteroids in cases of severe or uncontrolled asthma. Source:
NCBI:
Cromolyn
Sodium for
Asthma
Intal inhalers and nebulizer solutions are packaged in various quantities and dosage forms. The package insert contains detailed prescribing information, including proper storage conditions, expiration dates, and handling instructions.
Intal products should be stored at room temperature, protected from moisture and direct sunlight. Source:
FDA Label:
Intal
Inhalation Aerosol
The cost of
Intal can vary depending on the formulation, dosage, and location. Generic cromolyn sodium inhalation products are generally more affordable than the brand-name
Intal. Patients can explore coupons, discount programs, and insurance coverage to reduce out-of-pocket expenses. Ph
armacies like CVS and Walgreens may offer savings opportunities for
Intal and other asthma medications. Source:
GoodRx:
Intal Prices and Coupons
Proper patient education is crucial for ensuring the safe and effective use of
Intal. Healthcare professionals should provide detailed instructions on inhaler technique, dosage timing, and the importance of adhering to the prescribed regimen. Patients should also be advised to monitor their asthma symptoms and report any concerns or side effects promptly. Source:
American Lung Association:
Asthma Education Resources
Healthcare professionals play a vital role in prescribing and overseeing the use of
Intal. Guidelines for appropriate prescribing, dosage adjustments, and monitoring should be followed. Resources for healthcare professionals, such as product information, clinical practice guidelines, and drug interaction databases, are available from reputable sources. Source:
UpToDate:
Cromolyn
Sodium Drug Information
Intal inhalation aerosol was initially approved by the FDA in 1973, while the inhalation capsule formulation was later discontinued due to safety concerns. The regulatory status of
Intal and cromolyn sodium products may vary across different countries, with some regions imposing specific guidelines or restrictions. Source:
FDA:
Intal Approval History
The
Intal Nebulizer Solution is a clear, colorless, sterile solution with a pH of approximately 5.5. It is supplied in single-use ampules containing 20 mg of cromolyn sodium per 2 ml. The nebulizer solution is administered through a compatible nebulizer device for inhalation. Source:
FDA Label:
Intal
Inhalation Aerosol
Cromolyn sodium, the active ingredient in
Intal, belongs to the chromone complex family. It exerts its anti-inflammatory effects by stabilizing mast cells and preventing the release of chemical mediators, such as histamine, leukotrienes, and prostaglandins, which can trigger bronchospasms and airway inflammation. Source:
NCBI:
Cromolyn
Sodium for
Asthma
Various patient support groups and organizations provide resources and educational materials for individuals living with asthma. These resources can offer valuable information on managing the condition, coping strategies, and access to support networks. Source:
Asthma and
Allergy Foundation of America
The FDA halted the marketing and distribution of
Intal
Inhalation Capsules in 2006 due to concerns over potential risks associated with the formulation. Patients who were previously using the inhalation capsules were advised to consult their healthcare providers for alternative treatment options. Source:
FDA: Discontinuation of
Intal
Inhalation Capsules
Ongoing research efforts continue to explore the potential applications of cromolyn sodium and other mast cell stabilizers in the treatment of various respiratory and allergic conditions. Additionally, researchers are investigating novel drug delivery systems and formulations to improve the efficacy and convenience of cromolyn sodium inhalation therapies. Source:
NCBI: Mast Cell Stabilizers in
Asthma
Intal –
Cromolyn
Sodium
Inhalation Aerosol Guide
Table of Contents
Introduction
armacology/”>Ph
armacology
Indications and Usage
Formulations and Administration
Dosage and Guidelines
Side Effects and Adverse Reactions
Comparison and Alternatives
Clinical Studies and Efficacy
Packaging and Storage
Economic Considerations
Patient Education
Healthcare Professional Information
Legal and Regulatory Aspects
Intal Nebulizer Solution
Chemistry and Biology
Patient Support and Resources
Discontinuation and
Withdrawal
Current Research and Future Directions
